Nuytemans Karen, Inchausti Vanessa, Beecham Gary W, Wang Liyong, Dickson Dennis W, Trojanowski John Q, Lee Virginia M-Y, Mash Deborah C, Frosch Matthew P, Foroud Tatiana M, Honig Lawrence S, Montine Thomas J, Dawson Ted M, Martin Eden R, Scott William K, Vance Jeffery M
University of Miami, Miller School of Medicine, John P. Hussman Institute for Human Genomics, Miami, Florida, USA.
Mov Disord. 2014 May;29(6):827-30. doi: 10.1002/mds.25838. Epub 2014 Feb 26.
We have reported that intermediate repeat lengths of the C9ORF72 repeat are a risk factor for Parkinson's disease (PD) in a clinically diagnosed data set. Because 10% to 25% of clinically diagnosed PD have different diagnoses upon autopsy, we hypothesized that this may reflect phenotypic heterogeneity or concomitant pathology of other neurodegenerative disorders.
We screened 488 autopsy-confirmed PD cases for expansion haplotype tag rs3849942T. In 196 identified haplotype carriers, the C9ORF72 repeat was genotyped using the repeat-primed polymerase chain reaction assay.
No larger (intermediate or expanded) repeats were found in these autopsy-confirmed PD samples. This absence of larger repeats is significantly different from the frequency in clinically diagnosed datasets (P = 0.002).
Our results suggest that expanded or intermediate C9ORF72 repeats in clinically diagnosed PD or parkinsonism might be an indication of heterogeneity in clinically diagnosed PD cases. Further studies are needed to elucidate the potential contribution of the C9ORF72 repeat to autopsy-confirmed PD.
我们已经报道,在一个临床诊断数据集中,C9ORF72重复序列的中等重复长度是帕金森病(PD)的一个风险因素。由于10%至25%临床诊断为PD的患者在尸检时有不同的诊断结果,我们推测这可能反映了表型异质性或其他神经退行性疾病的伴随病理学。
我们对488例尸检确诊的PD病例进行了扩展单倍型标签rs3849942T的筛查。在196名确定的单倍型携带者中,使用重复引物聚合酶链反应分析对C9ORF72重复序列进行基因分型。
在这些尸检确诊的PD样本中未发现更大(中等或扩展)的重复序列。这种更大重复序列的缺失与临床诊断数据集中的频率有显著差异(P = 0.002)。
我们的结果表明,临床诊断的PD或帕金森综合征中扩展或中等的C9ORF72重复序列可能表明临床诊断的PD病例存在异质性。需要进一步研究以阐明C9ORF72重复序列对尸检确诊的PD的潜在贡献。